Cells naturally send tiny packages to one another to share information. Researchers at Carnegie Mellon University have developed a simple, low-cost way to turn those packages into drug carriers that can deliver treatments directly to cancer cells, potentially improving effectiveness while reducing side effects.
Customizable DNA Labels Enhance Targeted Drug Delivery to Cancer Cells
Researchers at Carnegie Mellon University have developed a low-cost method to create customizable DNA labels that can guide drug carriers to cancer cells. This innovation could enhance cancer treatment effectiveness while minimizing side effects. The advancement in medical technology could have implications for healthcare in Iran, particularly in cancer treatment.
👥 Key Players
📰 What Happened
Researchers at Carnegie Mellon University have created a low-cost method to produce customizable DNA labels that can direct drug carriers to cancer cells, potentially improving treatment effectiveness and reducing side effects.
- The method is simple and low-cost, making it accessible for wider use.
- This technology aims to enhance targeted drug delivery specifically for cancer treatment.
💡 Why It Matters
📚 Background
Cancer is a leading cause of death globally, and targeted therapies aim to deliver treatments directly to cancer cells, minimizing damage to healthy cells.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%